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Induction of Myocarditis and Valvulitis in Lewis Rats 
by Different Epitopes of Cardiac Myosin and Its 
Implications in Rheumatic Carditis 
Jeffrey E. Galvin,* Mark E. Hemric,* 
Stanley D. Kosanke,t Stephen M. Factor,+ 
Anthony Quinn,* and Madeleine W. Cunningham* 
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Patho!oR)"t Uniuersit), 0/ Oklahoma Health Sciences Cellter, 
Oklahoma City, Oklahoma: alld the Departnwllfs (!/l'alhology 
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Sell' }'ork 
Immune responses against cardiac myosin and group 
A streptococcal M protein have been implicated in the 
pathogenesis of rheumatic heart disease. Although 
cardiac myosin is known to produce myocarditis in 
susceptible animals, it has never been investigated for 
its role in production of valvular heart disease, the 
most serious sequelae of group A streptococcal infec-
tion in acute rheumatic fever. In our study, cardiac 
myosin induced valvulitis in the Lewis rat, and 
epitopes responsible for production of valvulitis were 
located in the rod region. Human and rat cardiac 
myosins induced severe myocarditis in the Lewis rats 
as expected. A purified S2 fragment (amino acid se-
quences 842 to 1295) produced the most severe myo-
carditis as well as valvulitis. Different regions of light 
meromyosin produced valvulitis (residues 1685 to 
1936) or myocarditis (residues 1529 to 1611). Because 
streptococcal M proteins produced valvular heart dis-
ease in Lewis rats and have been linked to anti-cardiac 
myosin responses, we reacted myosin-sensitized lym-
phocytes isolated from the hearts of Lewis rats with 
peptides of streptococcal M5 protein in tritiated thy-
midine assays. Inf'tltrating lymphocytes responded 
most strongly to peptides within the B repeat region 
of streptococcal M protein. These data show direct 
evidence that immune responses against cardiac my-
osin lead to valvular heart disease and the inf'tltration 
of the heart by streptococcal M protein reactive T 
lymphocytes. (AmJ Patho12002, 160:297-306) 
Infectious pathogens, including viruses,1 group A strep-
tococci,2 or chlamydia3 are important etiological agents 
of inflammatory heart disease, However, immune and 
specifically autoimmune mechanisms are the major ef-
fectors of pathogenic injury 4 The autoantigen most often 
associated with both myocarditis and rheumatic carditis 
is cardiac myosin, 2513 ln 1985, myosin was identified as 
an autoantigen involved in cross-reactivity between the 
group A streptococcus and heart,14 Since this time, evi-
dence has supported the molecular mimicry hypothesis 
that streptococcal M protein and the group A carbohy-
drate both induce anti-myosin responses that attack the 
heart.715-19 Rheumatic carditis and myocarditis may 
have similar pathogenic mechanisms because immuno-
logical mimicry was demonstrated between streptococ-
cal M protein and myocarditic coxsackieviruses and both 
were associated with cytotoxic antibody against heart 
cells as well as T-Iymphocyte responses,18,20-22 Pep-
tides of streptococcal M protein were shown to produce 
myocarditis in mice7 and intact recombinant streptococ-
cal M protein produced valvular heart disease in Lewis 
rats, 17 Studies also suggested that a myocarditic peptide 
of streptococcal M protein, which mimics cardiac myosin, 
tolerated and protected MRL/+ + mice against autoim-
mune myocarditis after coxsackieviral infection 23 How-
ever, it is debated as to whether or not mimicry between 
coxsackieviruses and cardiac myosin plays a role in the 
pathogenesis of myocarditis,24,25 
There is strong evidence that cardiac myosin is a domi-
nant autoantigen in autoimmune myocarditis8 and viral-in-
duced myocarditis,10 Investigators have demonstrated that 
myosin-induced myocarditis can be adoptively transferred 
by CD4+ T lymphocytes,12 In addition to T cells, passive 
administration of anti-myosin monoclonal antibody was 
found to induce myocarditis in DBA/2 but not BALB/c mice 
because of the presence of myosin or a myosin-like protein 
in the extracellular matrix of DBN2 mice,26 Gauntt and 
colleagues27-29 investigated the relationship between cox-
sackievirus and myosin and suggested that molecular mim-
icry between myosin and coxsackieviruses may playa role 
in myocarditis, Anti-coxsackieviral-neutralizing antibody 
produced myocardial inflammation in mice,27 In rheumatic 
carditis, group A streptococcal infection plays a major role 
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and anti-myosin antibody is associated with disease3031 
Monoclonal anti-myosin antibody has been shown to be 
cytotoxic for heart cells in culture and was found to recog-
nize laminin on the valve and myocyte cell surface. 15,16 
Antibodies in rheumatic carditis deposit in myocardium as 
well as valvular endothelium,16,32,33 and streptococcal M 
protein reactive T cells were found in human rheumatic 
valves34 Thus, in inflammatory heart diseases, myocarditis, 
and rheumatic carditis, both antibody and T cells are impli-
cated in the disease. 
Although valvulitis is the most serious complication of 
rheumatic fever and leads to the development of rheu-
matic heart disease,35 animal models of valvulitis have 
not been previously investigated. In addition, the role of 
cardiac myosin in valvular heart disease has not been 
previously addressed. In our study, we identified 
epitopes in human cardiac myosin (HCM) that induced 
valvulitis in Lewis rats. In the light meromyosin (LMM) 
region, myocarditis- and valvulitis-inducing epitopes 
could be separated, but the S2 rod fragment produced 
both myocarditis and valvulitis. Our data show that val-
vulitis was induced by immunization with cardiac myosin, 
cardiac myosin subfragments, heavy meromyosin 
(HMM), or S2, and with one region in LMM that was 
different from a site in LMM that produced myocarditis. 
Furthermore, lymphocytes isolated from the hearts of 
Lewis rats with myocarditis and valvulitis proliferated in 
the presence of specific streptococcal M5 protein pep-
tides. These data show direct evidence that immune 
responses against cardiac myosin can induce valvular 
heart disease and the infiltration of the heart by strepto-
coccal M protein-reactive T lymphocytes. 
Materials and Methods 
Antigens 
Bovine serum albumin, rabbit skeletal tropomyosin, rab-
bit skeletal HMM, and rabbit skeletal LMM were pur-
chased from Sigma Chemical Co., St. Louis, MO. Pep-
tides from the LMM region of HCM and the streptococcal 
M5 protein were synthesized on a Dupont RAMPS man-
ual peptide synthesizer using the f-moc strategy by the 
Molecular Biology Resource Center at the University of 
Oklahoma Health Sciences Center, Oklahoma City, OK 
(Dr. Ken Jackson, Director). Peptides were synthesized 
as 18-mers with a five-amino acid overlap. The strepto-
coccal M5 peptides represented the sequence of the 
type 5 streptococcal M protein of the Streptococcus pyo-
genes (Manfraedo strain). The amino acid sequences of 
the human cardiac LMM peptides are shown in Table 1 
and the streptococcal M5 peptides are shown in Table 2. 
Myosin Purification 
Cardiac myosin was purified from human (HCM) and rat 
(RCM) heart tissue, and human skeletal myosin was pu-
rified from human quadriceps tissue according to Tobac-
man and colleagues36 with slight modifications. Briefly, 
heart tissue was homogenized in a low salt buffer [40 
Table 1. Human Cardiac Light Meromyosin Peptides 
Peptide no. 
LMM-1 
LMM-2 
LMM-3 
LMM-4 
LMM-5 
LMM-6 
LMM-7 
LMM-S 
LMM-9 
LMM-10 
LMM-11 
LMM-12 
LMM-13 
LMM-14 
LMM-15 
LMM-16 
LMM-17 
LMM-18 
LMM-19 
LMM-20 
LMM-21 
LMM-22 
LMM-23 
LMM-24 
LMM-25 
LMM-26 
LMM-27 
LMM-28 
LMM-29 
LMM-30 
LMM-31 
LMM-32 
LMM-33 
LMM-34 
LMM-35 
LMM-36 
LMM-37 
LMM-38 
LMM-39 
LMM-40 
LMM-41 
LMM-42 
LMM-43 
LMM-44 
LMM-45 
LMM-46 
LMM-47 
LMM-48 
LMM-49 
Amino acid sequence 
KEALISSL TRGKL TYTOO 
TYTOOLEDLKROLEEEVK 
EEEVKAKNALAHALOSAR 
LOSARHDCDLLREOYEEE 
EOYEEETEAKAELORVLSK 
RVLSKANSEVAOWRTKYE 
RTKYETDAIORTEELEEA 
ELEEAKKKLAORLOEAEE 
OEAEEAVEAVNAKCSSLE 
CSSLEKTKHRLONEIEDL 
EI EDLMVDVERSNAAAAA 
AAAAALDKKORNFDKILA 
DKILAEWKOKYEESOSEL 
SOSELESSOKEARSLSTE 
SLSTELFKLKNAYEESLE 
EESLEHLETFKRENKNLO 
NKNLOEEISDL TEOLGSS 
EOLGSSGKTIHELEKVRKO 
KVRKOLEAEKMELOSALE 
LOSALEEAEASLEHEEGKI 
EEG KI LRAOLEFNOI KAE 
NOI KAEI ERKLAEKDEEME 
DEEMEOAKRNHLRVVDSL 
VVDSLOTSLDAETRSRNE 
RSRNEALRVKKKMEGDLN 
EGDLNEMEIOLSHANRMA 
ANRMAAEAOKOVKSLOSL 
SLOSLLKDTO IOLDDAVR 
RANDDLKENIAIVERRNN 
IAIVERRNNLLOAELEEL 
ELEELRAVVEOTERSRKL 
RSRKLAEOELI ETSERVO 
SERVOLLHSONTSLINOK 
LlNOKKKMDADLSOLOTE 
TEVEEAVOESRNAEEKAKK 
RNAEEKAKKAITDAAMMA 
AAMMAEELKKEODTSAHL 
TSAHLERMKKNMEOTIKDL 
TI KDLOHRLDEAEO IALK 
EOIALKGGKKOLOKLEARV 
LEARVRELENELEAEOKR 
AEOKRNAESVKGMRKSER 
RKSERRIKEL TYOTEEDR 
TEEDRKNLLRLODLVDKL 
LVDKLOLKVKAYKROAEE 
ROAEEAEEOANTNLSKFR 
LSKFRKVOHELDEAEERA 
AEERADIAESOVNKLRAK 
KLRAKSRDIGTKGLNEE 
Residue no. 
1295-1312 
1308-1325 
1321-1338 
1334-1351 
1346-1364 
1360-1376 
1373-1390 
1386-1403 
1399-1416 
1412-1429 
1425-1442 
1438-1455 
1451-1468 
1464-1481 
1477-1494 
1490-1507 
1503-1520 
1516-1533 
1529-1546 
1542-1559 
1555-1572 
1568-1585 
1581-1598 
1594-1611 
1607-1624 
1620-1637 
1633-1650 
1646-1663 
1659-1676 
1672-1689 
1685-1702 
1698-1715 
1711-1728 
1724-1741 
1737-1754 
1750-1767 
1763-1780 
1777-1794 
1790-1807 
1802-1820 
1816-1833 
1829-1846 
1842-1859 
1855-1872 
1868-1885 
1881-1898 
1894-1910 
1907-1923 
1920-1936 
mmol/L KCI, 20 mmol/L imidazole (pH-7.0), 5 mmol/L 
EGTA, 5 mmol/L dithiothreitol, 0.5 mmol/L phenylmethyl 
sulfonyl fluoride (PMSF), and 1 /-tg/ml leupeptin] for 15 
seconds on ice. The washed myofibrils were collected by 
centrifugation at 16,000 x g for 10 minutes. The myofi-
brils were then resuspended in high-salt buffer (0.3 mol/L 
KCI, 0.15 mol/L K2HP04, 1 mmol/L EGTA, 5 mmol/L di-
thiothreitol, 0.5 mmol/L PMSF, and 1 /-tg/mlleupeptin) and 
homogenized for three 30-second bursts on ice. The 
homogenized tissue was further incubated on ice with 
stirring for 30 minutes to facilitate actomyosin extraction. 
After clarification by centrifugation, actomyosin was pre-
cipitated by adding 10 volumes of cold water and adjust-
ment of the pH to 6.5. Dithiothreitol was added to 5 
mmol/L and the precipitation allowed to proceed for 30 
minutes. The actomyosin was then collected by centrifu-
Reproduced with permission of the copyright owner.  Further reproduction prohibited without permission.
Table 2. Amino Acid Sequence of Type 5 M Protein 
Peptides' 
NT-1t 
NT-2 
NT-3 
NT-4 
NT-5 
NT-6 
NT-7 
NT-8 
B1-A 
B1-B 
B1-B2 
B2 
B2-B3A 
B3A 
B2-B3B 
B3B 
C1A 
C1B 
C1-C2 
C2A 
C2B 
C2-C3 
C3 
AVTRGTINDPORAKEALD 
KEALDKYELENHDLKTKN 
LKTKNEGLKTENEGLKTE 
GLKTENEGLKTENEGLKTE 
KKEHEAENDKLKOORDTL 
ORDTLSTOKETLEREVON 
REVONTOYNNETLKIKNG 
KIKNGDL TKELNKTROEL 
TROELANKOOESKENEKAL 
ENEKALNELLEKTVKDKI 
VKDKIAKEOENKETIGTL 
TIGTLKKILDETVKDKIA 
KDKIAKEOBNKETIGTLK 
ITGLKKILDETVKDKLAK 
DKLAKEOKSKONIGALKO 
GALKOELAKKDEANKISD 
NKISDASRKGLRRDLDAS 
DLDASREAKKOLEAEHKO 
AEHOKLEEONKISEASRK 
EASRKGLRRDLDASREAK 
SREAKKOLEAEOOKLEEO 
KLEEONKISEASRKGLRR 
KGLRRDLDASREAKKO 
-Predicted amino acid sequence of serotype 5 M protein from S, 
pyogenes, strain Manfredo, 
tpeptides represent the sequence found in the amino terminal 
region (NT), and 8 (8) and C (C) repeat regions of the M5 protein. 
gation at 16,000 x g, The actomyosin pellet was then 
resuspended in high-salt buffer, ammonium sulfate was 
increased to 33%, and the KCI concentration was in-
creased to 0,5 mol/L, After the actomyosin pellet and 
salts were dissolved, ATP was added to 10 mmol/L, 
MgCI2 was added to 5 mmol/L, and the solution was 
centrifuged at 20,000 x g for 15 minutes to remove actin 
filaments, The supernatant was removed and stored at 
4°C in the presence of the following inhibitors: 0,5 mmol/L 
PM SF, 5 p,g/ml TLCK, and 1 p,g/ml leupeptin, 
Isolation of Cardiac Myosin Fragments 
The myosin molecule can be divided into subfragments 
through proteolysis, At lower ionic strengths, chymotryp-
tic cleavage yields subfragment-1 (S1) and myosin rod; 
whereas, at higher ionic strength, chymotryptic cleavage 
yields HMM and LMM, Further cleavage of HMM yields 
S1 and S2 subfragments, Purified subfragments and syn-
thetic LMM peptides from HCM that were tested in Lewis 
rats are shown in Figure 1, Purity of all proteins was 
assessed using sodium dodecyl sulfate-polyacrylamide 
gel electrophoresis, and in some cases, fragments re-
quired further purification by ammonium sulfate precipi-
tation and/or diethyl amino ethyl ion exchange chroma-
tography, 
Human Myosin Subfragment-1 
In our studies, S1 was produced from purified HCM ac-
cording to Tobacman and colleagues36 with slight mod-
ification, Briefly, myosin was dialyzed against digestion 
buffer (0,1 mol/L NaCI, 0,01 mol/L imidazole-HCI, pH 7, 
and 0,001 mol/L dithiothreitol) and cleaved with a 1: 1 00 
Cardiac Myosin Epitopes in Myocarditis and Valvulitis 299 
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842 1295 1936 
Cardiac myosin I I I 
1295 
HMM I 
842 
SI I 
596 1295 
S2 I I 
1295 1936 
LMM peptide groups L---__ J 
Figure 1. Diagram of HCM, cardiac myosin subfragments, and LMM peptide 
groups, H:VI:V1. subfragment-l (51), and subfragment-2 (S2) were enzymati-
cally cleaved and purified as described in Malerials and Methods and as 
shown in the diagram, Each of the eight L:V1M peptide groups consisted of six 
consecutive, overlapping, synthetic peptides. The LMM peptides correspond 
to the LMM region of HCM as shown, 
w/w ratio of a-chymotrypsin to myosin for 15 minutes at 
25°C, The reaction was terminated by the addition of 
PMSF to a final concentration of 0,3 mmol/L, The rod and 
uncleaved myosin were precipitated by dialysis in a low 
salt solution (10 mmol/L NaCI, 10 mmol/L imidazole, pH 
7,0, 1 mmol/L dithiothreitol) and then separated from the 
soluble S1 by centrifugation at 20,000 X g, 
Human Cardiac HMM 
The HMM subfragment of HCM was prepared according 
to a previously described procedure with slight modifica-
tions,37 Briefly, HMM was prepared by digesting myosin 
with a chymotrypsin 100:1 w/w ratio in 0,6 mol/L KCI, 2 
mmol/L MgCI2, 1 mmol/L dithiothreitol, and 0,01 mol/L 
Tris-HCI (pH 7,6) for 10 minutes at 25°C, The reaction 
was terminated by adding PMSF to a final concentration 
of 0,2 mmol/L, The LMM and uncleaved myosin were 
precipitated by dialysis in a low-salt solution (0,03 mol/L 
KCI, 0,01 mol/L potassium phosphate, pH 6,3, 1 mmol/L 
dithiothreitol, and 1 mmol/L MgCI 2 ) and then separated 
from the soluble HMM by centrifugation at 20,000 x g, 
S2 Fragment of Human Cardiac Myosin 
Normally, S2 subfragment of cardiac myosin was pre-
pared by controlled proteolysis of purified HMM subfrag-
men!. However, in these studies, an S2-containing frag-
ment was produced from purified preparations of human 
cardiac HMM that seemed to be proteolyzed by an innate 
protease, The S2 fragment was purified by applying the 
innately proteolyzed preparation of HMM to S-400 gel 
filtration chromatography, Identity of S2 was confirmed 
by N-terminal sequencing using the Edman degradation 
method, Myosin subfragments are shown in a diagram in 
Figure 1, 
Immunization 
Female Lewis rats (6- to 8-weeks old) were purchased 
from Harlan-Sprague-Oawley (Indianapolis, IN) and 
Reproduced with permission of the copyright owner.  Further reproduction prohibited without permission.
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maintained in groups of three or four at the Animal Re-
sources Facility on the campus of the University of Okla-
homa Health Sciences Center, Five hundred p,g of pro-
tein or peptide was emulsified in Freund's complete 
adjuvant at a 1: 1 ratio (v/v) and injected into one hind 
footpad of rats anesthetized with 10 mg of ketamine/0.2 
mg of xylazine. On days 1 and 3 after immunization, the 
rats were intraperitoneally administered 1 x 10 10 killed 
Bordetella pertussis organisms as an adjuvant. Seven 
days after the primary immunization rats were boosted 
subcutaneously with 500 p,g of protein or peptide emul-
sified in Freund's incomplete adjuvant (1:1 ratio), Control 
rats received phosphate-buffered saline (PBS) or bovine 
serum albumin emulsified in Freund's adjuvant and B. 
pertussis injections. 
Histopathological Examination of Tissue 
Rats were terminated 21 days after the primary immuni-
zation by cardiac puncture while under anesthesia. 
Heart, liver, and kidneys were excised and fixed in 10% 
buffered formalin. After routine tissue preparation (ie, 
paraffin embedding, slide mounting, and hematoxylin 
and eosin staining), myocardium was blindly scored for 
the presence of histopathological myocarditis according 
to the following scale: 0 = normal, 1 = mild «5% of heart 
cross-section involved), 2 = moderate (5 to 10% of cross-
section involved), 3 = marked (10 to 25% of cross-sec-
tion involved), 4 = severe (>25% of cross-section in-
volved). Valve tissue was observed for the presence of 
cellular infiltrates. Liver and kidneys were also evaluated 
for abnormalities, but were found to be normal. 
Isolation and Proliferation Assay of 
Lymphocytes Infiltrating Hearts in Cardiac 
Myosin-Induced Myocarditis and Valvulitis 
Inflamed hearts from Lewis rats with myocarditis/valvulitis 
were perfused with heparinized Iscove's modified Dul-
becco's medium, minced, and treated with collagenase 
at 160 U/ml (Sigma Chemical Co) for 30 minutes at 37°C, 
The tissue was then pressed through a screen to obtain a 
single cell suspension and washed with Iscove's modi-
fied Dulbecco's medium, The cell suspension was sep-
arated in Ficoll Hypaque (Sigma Chemical Co.) and lym-
phocytes recovered after centrifugation. The cells were 
washed in Iscove's modified Dulbecco's medium and 
were resuspended in proliferation medium and reacted 
with M5 peptides in the tritiated thymidine uptake assay 
using 5 x 103 cells/well. To provide additional antigen 
presenting cells,S x 103 mitomycin C-treated normal rat 
spleen cells were added to each well. Proliferation me-
dium consisted of Iscove's modified Dulbecco's medium, 
2% rat serum, 50 p,mol/L 2-mercaptoethanol, 100 U pen-
icillin, and 100 p,g streptomycin and streptococcal M5 
peptide at 20 /Lg/ml. Wells were pulsed with 1.0 /LCi of 
tritiated thymidine (ICN, Irvine, CAl 18 hours before being 
harvested onto filters with a cell harvester. Tritiated thy-
midine incorporation was measured by a liquid scintilla-
Table 3. Induction of :Vlyocarditis in Lewis Rats by 
Immunization with Cardiac Myosin, Myosin 
Suhfragments, or LMM Peptides 
Average 
Myocarditis lesion 
Immunogen (positive/total) score* 
Whole molecule 
Human cardiac myosin 18/23 3.0 
Rat cardiac myosin 13/13 3.4 
Subfragments of HCM 
HMM subfragment of HCM 5/5 4.0 
S 1 subfragment of HCM 0/7 0 
S2 subfragment of HCMt 3/3 3.8 
Related molecules and 
fragments 
Human skeletal myosin 0/6 0 
Rabbit skeletal LMM 0/5 0 
Rabbit skeletal HMM 0/3 0 
Rabbit skeletal tropomyosin 0/6 0 
Light meromyosin peptides 
LMM peptides 1-6t 1/9 2.5 
LMM peptides 7-12 1/6 0.5 
LMM peptides 13-18 0/6 0 
LMM peptides 19-24 5/11 2.0 
LMM peptides 25-30 0/6 0 
LMM peptides 31-36 0/6 0 
LMM peptldes 37-42 0/4 0 
LMM peptides 43-49 0/6 0 
Controls 
Bovine serum albumin 0/6 0 
PBS + adjuvants 0/34 0 
'Lesions were scored histologically based on the following scale: 
o = normal. 1 = mild (less than 5% of cross section involved). 2 = 
moderate (5 to 10% of cross section Involved), 3 = marked (10-25% of 
cross section involved), 4 = severe (greater than 25% 01 cross section 
involved). 
tNlnety live kd sublragment of human cardiac myosin containing the 
S2 region as determined by Edman degradation. 
+LMM peptide sequences are listed in Table 1 
tion counter. Values represent the stimulation index (stim-
ulation index equals test counts per minute/media control 
counts per minute). 
Results 
Induction of Myocarditis with Cardiac Myosin, 
Subfragments, and LMM Pep tides 
Lewis rats immunized with HCM developed severe clini-
cal and histological myocarditis as expected (Table 3 
and Figure 2a). This response was specific for the car-
diac isoform as immunization with human skeletal myo-
sin, rabbit skeletal LMM, and rabbit skeletal HMM did not 
cause myocarditis (Table 3). Additionally, rabbit skeletal 
tropomyosin, and bovine serum albumin did not induce 
myocarditis (Table 3). Lewis rats immunized with rat car-
diac myosin (RCM) developed myocarditis that was clin-
ically and histologically indistinguishable from myocardi-
tis induced by HCM (Table 3 and Figure 2b), Histological 
lesions displayed intense inflammatory infiltrates consist-
ing of lymphocytes, macrophages, neutrophils, and 
multinucleated giant cells (Figure 2, a and b). 
To confirm and extend knowledge about epitopes that 
produce myocarditis in the Lewis rat, purified HCM sub-
Reproduced with permission of the copyright owner.  Further reproduction prohibited without permission.
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Figure 2. Histopathological feature-; uf autoimmune myocarditis in Lc\vis 
rats. Ammals were immunized with HC"l (a). RCM (bJ. H"lM fragment of 
HCM (e). S2 fragment of HC:VI td). HC"l L:VlM peptides 19 to 24 tel. and PBS 
plus adjtl\ ants (f) as described in Material and Methods. Levlis rats in1n1U-
nized with human or RCM, LMM peptide group 19 to 24. HMM fragment, or 
S2 fragment of HeM exhibit myocyte necro~is in the myocardium with 
intense inflammatory infiltrates (a-e). Control rats in1l11unized with PBS plus 
adjuvants (f) or \vith bovine serum albumin plus adjuvants (not sho\vn) have 
no detectable histopathological 1c:-.ions. Original magnification,',,: X 200 (left 
panels): X ,.00 (right panels). 
fragments HMM. S1, and S2, were administered to Lewis 
rats. HMM is a large subfragment of myosin comprised of 
the S1 and 82 segments of the molecule (see diagram in 
Figure 1). When administered to Lewis rats, HMM in-
duced severe disease in 100% (five of five) of rats (Table 
3, Figure 2c). All five animals had severe clinical signs of 
disease, and the histopathological lesions were through-
out a large portion of the heart and scored as severe 
(Table 3). Immunization with the globular head or S1 
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portion of the cardiac myosin molecule did not induce 
myocarditis (Table 3), suggesting that disease-produc-
ing epitopes in the Lewis rat were confined to the rod 
region. 
To further analyze the rod region, an S2 fragment, 
whose molecular mass was estimated at 95 kd by sodium 
dodecyl sulfate-polyacrylamide gel electrophoresis, was 
purified from human cardiac HMM. Edman degradation 
sequence analysis of the first five amino acids of this 
fragment revealed that the N terminus was at amino acid 
residue 596 (sequence: KNKDP). Therefore, this HCM 
fragment extended from amino acid residue 596 to resi-
due 1295 (the C-terminal end of the HMM molecule) and 
contained the entire S2 portion of the HCM molecule. 
When administered to Lewis rats, the extended S2 sub-
fragment of HCM induced severe myocarditis, compara-
ble to that induced by the intact myosin molecule and 
HMM (Table 3). The histopathological lesions from Lewis 
rats immunized with the S2 fragment are shown in Figure 
2d. Severe myocyte necrosis of the myocardium was 
observed and the inflammatory cell infiltrate consisted of 
mononuclear cells and neutrophils. Control animals im-
munized with bovine serum albumin or PBS plus adju-
vants had no detectable myocardial inflammation (Table 
3 and Figure 2f). These results confirmed that the S1 
fragment did not induce disease and that the S2 region 
strongly induced myocarditis in Lewis rats. 
For localization of myocarditic epitope(s) in the LMM 
tail fragment of the myosin rod, 49 overlapping 18-mer 
peptides that span the LMM region of the cardiac myosin 
molecule were synthesized (Table 1) based on published 
sequences 38 Because no single LMM peptide could 
induce disease, the LMM peptides were tested for myo-
carditis as eight peptide groups with six consecutive 
peptides comprising each LMM peptide group (Table 3). 
The LMM peptide group containing peptides 1 to 6 in-
duced moderate inflammation in only one of nine animals 
indicating a very minor pathogenic epitope (Table 3). 
However, the peptide group containing LMM peptides 19 
to 24 induced moderate myocarditis in 45% (5 of 11) of 
the animals tested (Table 1, Figure 2e). LMM peptides 19 
to 24 corresponded to amino acid residues 1529 to 1611 
in HCM. Although, myocarditis was induced by the LMM 
19- to 24-peptide group in -50% of the rats, severity was 
less than that induced by intact cardiac myosin, HMM, or 
S2 subfragments, suggesting that the site in LMM may 
not be a dominant myocarditic region for Lewis rats. By 
comparing the different regions of the cardiac myosin 
molecule in a single study, it allowed us to identify the 
most and the least myocarditic regions in the Lewis rat 
model and to put these epitopes in perspective with 
disease. 
Cardiac Myosin-Induced Valvulitis in Lewis Rats 
Valve tissue from Lewis rats immunized with HCM and its 
subfragments was obtained and examined histopatho-
logically for the presence of inflammatory cells (ie, valvu-
litis). Forty-three percent of Lewis rats immunized with 
HCM and 46% of rats given RCM developed valvulitis 
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Table 4. Induction of Valvulitis in Lewis Rats by 
Immunization with Cardiac Myosin, Myosin 
Subfragments, or LMM Peptides 
Immunogen 
Whole molecule 
Human cardiac myosin 
Rat cardiac myosin 
Subfragments of HCM 
HMM 
S1 
S2 
Related molecules 
Human skeletal myosin 
Light meromyosin peptides 
LMM peptides 1--B 
LMM peptides 7-12 
LMM peptides 13-18 
LMM peptides 19-24 
LMM peptides 25-30 
LMM peptides 31-36 
LMM peptides 37-42 
LMM peptides 43-49 
Controls 
Bovine serum albumin 
PBS + adjuvants 
Valvulitis' 
(positive/total) 
10/23 
6/13 
4/5 
0/4 
2/3 
0/6 
0/6 
0/6 
0/6 
0/11 
0/6 
2/6 
2/4 
2/6 
0/6 
0/34 
'Presence of inflammatory cells in valve tissue were indicated as 
shown in Figure 3. The level of valvulitis was similar in peptide groups 
31 to 36, 37 to 42, and 43 to 49. These peptide groups produced a 
similar valvulitis that was seen as cellular infiltration at the valvular 
surface endothelium. In some instances, the valvulitis was more severe 
for the whole cardiac myosin molecule. 
(Table 4). Although not every rat that developed myocar-
ditis developed valvulitis, at least half of the rats that 
developed myocarditis developed valvulitis. The valvular 
inflammation was characterized histopathologically as 
the presence of cellular infiltrates composed primarily of 
mononuclear cells within valve tissue (Figure 3, A and B). 
Skeletal myosin did not induce valvular inflammation (Ta-
ble 4). 
Localization of Valvulitis-Inducing Fragments of 
Cardiac Myosin 
Immunization with the cardiac HMM subfragment pro-
duced valvulitis in four of five animals (Table 4, Figure 3C) 
and immunization with S2 produced valvulitis in two of 
three animals (Table 4, Figure 3~). Using groups of syn-
thetic peptides (Table 1), three valvulitis-inducing 
epitopes were discovered in the LMM region of HCM 
(Table 4). One-third of Lewis rats immunized with LMM 
peptides 31 to 36 developed valvulitis (Table 4, Figure 
3E). LMM groups containing peptides 37 to 42 (Table 4, 
Figure 3F) and 43 to 49 (Table 4, Figure 3G) also induced 
valvulitis in two of four and two of six animals, respec-
tively. Control rats immunized with bovine serum albumin 
plus adjuvants or PBS plus adjuvants had no detectable 
valvular inflammation (Table 4, Figure 3H). Cells with 
caterpillar nuclei characteristic of Anitschkow cells, 
present in the valves of patients with rheumatic fever,35 
could be found scattered throughout the valves of Lewis 
rats immunized with cardiac myosin, HMM, or S2 sub-
fragments, and LMM peptides 31 to 36, 37 to 42, and 43 
to 49 (Figure 4). 
In summary, valvulitis-producing epitopes in cardiac 
myosin were located in the rod region. However, the 
epitopes in LMM that produced myocarditis (residues 
1529 to 1611) were located in a different region from 
those producing valvulitis (residues 1685 to 1936). How-
ever, both myocarditis and valvulitis were produced by 
the HMM and S2 subfragments, but not by the S1 sub-
fragment, suggesting that the most pathogenic epitope is 
in the S2 subfragment. 
Lymphocytes Infiltrating Hearts in Myocarditis 
and Valvulitis Proliferate to Group A 
Streptococcal M5 Pep tides 
Lymphocytes isolated from hearts after induction of car-
diac myosin-induced inflammatory heart disease were 
reacted with streptococcal M5 protein peptides to deter-
mine the responsiveness of myosin-sensitized lympho-
cytes to streptococcal M protein. Lymphocytes tested 
were isolated from inflamed hearts from four rats showing 
clinical signs of myocarditis. Lymphocytes from the myo-
cardial infiltrate proliferated to four M5 peptides including 
a group of overlapping peptides in the B repeat region of 
the streptococcal M protein including M5 peptides B1A, 
B 1 B, B 1 B2 that indicated stimulation indices of >2.0 
(Figure 5). Also elevated were two peptides in the C 
repeat region including C1C2 and C3. These data provide 
evidence that streptococcal M protein cross-reacts with 
myosin-sensitized T cells in hearts developing inflammatory 
heart disease such as myocarditis and valvulitis. 
Discussion 
Herein we report an animal model of valvular heart dis-
ease that to our knowledge has not been described. In 
addition, our novel observations in the Lewis rat show that 
cardiac myosin-induced valvular heart disease resem-
bled valve disease in rheumatic fever. Recently, we have 
shown that streptococcal recombinant M6 protein pro-
duced a striking cellular infiltration of the valve with focal 
lesions in myocardium. 17 In the M protein-induced valvu-
litis, the cellular infiltrates entered through the valve sur-
face suggesting that the valve endothelium is an impor-
tant location for entry of inflammatory cells rather than 
from myocardium. However, in the valvulitis associated 
with cardiac myosin-induced myocarditis, cellular infil-
trates were often observed in the myocardium adjacent to 
the valve. The evidence also suggests that sensitivity of 
Figure 3. Histopathological features of autoimmune valvulitis in Lewis rats. Animals were immunized with HeM (A). RCM (B). HMM fragment of HeM (el, S2 
fragmentofHCM CD), LMM peptide group 31 to 36 (E). L\1M peptide group 37 to 42 (F), LMM peptide group 43 to 49 (G), or PHS plus adjuvant, (H). Mononuclear 
cell infiltrates can be distinguished in the valves of Lewis rats immunized with human or ReM, HM.'VI fragment, S2 fragment of HCM. or L~!J'vl peptide groups (A-G). 
No mononuclear cell infiltrates could be detected in valves from control animals (H). Original magnifications: x400 (A-F): X200 (G and Hl. 
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Figure 4. Presence of Anitschkow-like cell:, in valves from Lewis rats immu-
nized with HMM from HCM. In addition to inflammatory cell infiltrates. cells 
with caterpillar nuclei morphology were observed (arrowheads). The 
Anitschkow-like cells shown in the figure are cut longitudinally and the 
condensed chromatin gives the appearance of a caterpillar. Cells with cater-
pillar nuclei were observed in valves from rats inlI11Unized with intact HeM, 
RCM. and HCM subfragments, and LMM peptides. 
Lewis rats to valvular heart disease is novel and will be 
useful to investigate the pathogenesis of rheumatic and 
immune-mediated valvular heart disease. 
Using rodent models, the role of cardiac myosin as an 
autoantigen in the pathogenesis of autoimmune myocar-
ditis has been well established8,9,11-13,394D Myocarditis 
can be induced by cardiac myosin in A/J mice,8,12 
BALB/c mice,3941 and in Lewis rats 9 ,13 However, 
C57BL/6 mice are resistant to myosin-induced myocar-
ditis. Exposure of cardiac myosin in the heart may be an 
important event leading to the onset of disease in the 
susceptible host42 Evidence has shown that in normal 
myocardium myosin-class II major histocompatibility an-
>< II) 
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3 
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Streptococcal M protein Peptides 
Figure 5. Reaction of lymphocytes infiltrating hearts in cardiac myosin-
induced myocarditis and valvulitis proliferated to group A streptococcal M'1 
peptides. Lymphocytes from the myocardial infiltrate proliferated to four 1'.15 
peptides including M5 peptides ilIA, BIB, and R1B2 with stimulation indices 
of > 2.0. Also with elevated stimulation indices \vere t\VO peptides in the C 
repeat region, CIC2 and C3. These data provide evidence that streptococcal 
M protein cross-reacts with myosin sensitized T cells in hearts developing 
inflammatory heart disease. 
tigen complexes are present before the induction of au-
toimmune myocarditis 43 Induction of myocarditis is seen 
only with cardiac myosin and not skeletal myosin B 
Unique epitopes within cardiac myosin have been de-
scribed to produce myocarditis. Myocarditis was in-
duced by amino acid residues 334 to 352, located in the 
S1 region of A/J mouse cardiac myosin, 11 residues 736 to 
1032 in BALB/c cardiac myosin,41 acetylated residues 
614 to 643 of RCM-produced disease in BALB/c mice,35 
residues 1070 to 1165 of porcine cardiac myosin-in-
duced disease in Lewis rats,38 residues 1107 to 1186 in 
the Lewis rat,44 and acetylated Lewis rat LMM region 
residues 1539 to 1555.13 Our study in Lewis rats sug-
gests that epitopes within the LMM region produce val-
vulitis whereas the most severe myocarditis was pro-
duced by the S2 region of cardiac myosin. 
We have found both CD4+ and CD8+ T cells present 
in valves and myocardium of cardiac myosin-induced 
myocarditis and valvulitis (data not shown). This is similar 
to what we have found in human rheumatic heart dis-
ease 45 The data also link epitopes of streptococcal M 
protein and cardiac myosin together because myosin-
sensitized lymphocytes from inflamed hearts proliferated 
to several streptococcal M protein peptides (Figure 5). 
This further supports the hypothesis that the Lewis rat is 
similar to the human, because T cells isolated from valves 
of humans with rheumatic heart disease proliferate to a 
similar group of peptides of streptococcal M5 protein 34 
The homology and a-helical coiled-coil structure shared 
between M protein and the cardiac myosin rod is signif-
icant enough that both produce inflammatory heart dis-
ease in Lewis rats. Although many M protein epitopes 
have been shown to be cross-reactive with myosin, only 
streptococcal M protein peptides sharing sequence ho-
mology with cardiac myosins produced myocardial in-
flammation in mice. 7 .23 Repeated regions of M proteins 
that share homology with only cardiac myosins may 
break tolerance to cardiac myosin and induce myocar-
dial disease.23 
Because cardiac myosin is not known to be present in 
the valve or expressed extracellularly in normal heart, 
how mimicry of cardiac myosin produces myocarditis 
and valvular heart disease is an important question. Our 
studies suggest that laminin may link myosin with the 
valve through cross-reactivity between the a-helical 
structures. Recently, a cytotoxic anti-myosin/anti-strepto-
coccal monoclonal antibody from rheumatic carditis was 
shown to recognize laminin, an extracellular matrix a-he-
lical coiled-coil protein that is an integral part of the valve 
structure as well as present in the extracellular matrix 
surrounding the cardiomyocyte. 16.20.46 Evidence pre-
sented in previous work supports the hypothesis that 
laminin, present in the basement membrane of the valve 
and secreted by endothelial cells, is a target of cross-
reactive anti-myosin/anti-streptococcal antibody. Laminin 
present in valves and myocardium may cross-react with 
anti-myosin/anti-Iaminin T cells and antibody that recog-
nize M protein, myosin, and laminin. Because cardiac 
myosin is an intracellular molecule, peptides of it may be 
presented to T cells during turnover in cardiac tissues 43 
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Exposure of cardiac myosin in damaged regions of the 
heart may also lead to inflammatory heart disease. 
A systematic approach was used to identify cardiac 
myosin epitopes responsible for myocarditis and valvuli-
tis. Valvulitis and myocarditis were observed in Lewis rats 
given the S2 fragment and HMM. In LMM, different 
groups of peptides produced valvulitis (residues 1685 to 
1936) or myocarditis (residues 1529 to 1611). Three dif-
ferent LMM regions (amino acids 1685 to 1767, 1763 to 
1846, and 1842 to 1936) were involved in production of 
valvulitis in the rats. The incidence of valvulitis induced by 
the cardiac myosin subfragments and LMM peptide 
groups was decreased when compared to intact cardiac 
myosin. This suggests that the valvulitis-inducing 
epitopes in cardiac myosin may act in concert to produce 
valvular inflammation. The present studies provide a di-
rect link between cardiac myosin and valvular inflamma-
tion suggesting that exposure of cardiac myosin may 
actively contribute to valvulitis during development of 
rheumatic heart disease. Collectively, our results demon-
strate that myocarditic epitopes for Lewis rats are located 
within the rod region of the cardiac myosin molecule in S2 
and LMM with the most pathogenic epitopes in S2. The 
myocarditis- and valvulitis-producing epitopes in the 
LMM region could be separated and were distinctly dif-
ferent and in two separate regions of the molecule. 
Our results demonstrated that myocarditis induced by 
self antigen RCM was indistinguishable from that induced 
by HCM. Rat cardiac a-myosin (dominant isoform ex-
pressed in adult rat heart) and human cardiac i3-myosin 
(dominant isoform expressed in human ventricle tissue) 
are 93% identical and 98% homologous at the amino acid 
sequence level. Mimicry of epitope(s) between HCM and 
RCM was sufficient to produce severe disease. Regard-
less of the source of cardiac myosin, myocarditis and 
valvulitis were induced in Lewis rats and multiple 
epitopes seemed to contribute to both diseases. The 
Lewis rat model of inflammatory heart disease will be a 
powerful tool for further investigation of the immunopatho-
genesis of human myocarditis and rheumatic valvulitis. 
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